A team of clinical trial tech veterans has raised $5 million to fund development and early marketing of a randomization and trial supply management system.
Organ-on-a-chip player Emulate has added $17 million to its Series B round and landed a deal with Covance.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
SoftBank is teaming up with Saudi Arabia’s sovereign wealth fund to invest up to $100 billion in tech companies over the next five years.
PierianDx has bought Tute Genomics to gain the genomics platform it built up over its four years of operation and through the takeover of Knome.
Zymergen has raised $130 million to advance its machine learning-enabled microbe design business.
Y Combinator alum Benchling has raised $7 million to advance its cloud electronic lab notebook and CRISPR design software.
Desktop Genetics, Horizon Discovery and Vectalys have teamed up to develop custom-made CRISPR lenti-gRNA libraries.
Illumina has agreed to comarket Dovetail Genomics’ genome assembly service, an offering that leverages short-read sequencers to deliver long-range information.
Jun Wang’s iCarbonX has dipped into its Series A haul to buy Imagu Vision, an Israeli startup active in identifying and analyzing medical images.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.